162 related articles for article (PubMed ID: 9562071)
1. The value of detection of flow voids between the uterus and the leiomyoma with MRI.
Torashima M; Yamashita Y; Matsuno Y; Takahashi M; Nakahara K; Onitsuka Y; Ohtake H; Tanaka N; Okamura H
J Magn Reson Imaging; 1998; 8(2):427-31. PubMed ID: 9562071
[TBL] [Abstract][Full Text] [Related]
2. "Bridging vascular sign" in the MR diagnosis of exophytic uterine leiomyoma.
Kim JC; Kim SS; Park JY
J Comput Assist Tomogr; 2000; 24(1):57-60. PubMed ID: 10667660
[TBL] [Abstract][Full Text] [Related]
3. Hyperintense uterine leiomyoma at T2-weighted MR imaging: differentiation with dynamic enhanced MR imaging and clinical implications.
Yamashita Y; Torashima M; Takahashi M; Tanaka N; Katabuchi H; Miyazaki K; Ito M; Okamura H
Radiology; 1993 Dec; 189(3):721-5. PubMed ID: 8234695
[TBL] [Abstract][Full Text] [Related]
4. The value of MR imaging in distinguishing leiomyomas from other solid pelvic masses when sonography is indeterminate.
Weinreb JC; Barkoff ND; Megibow A; Demopoulos R
AJR Am J Roentgenol; 1990 Feb; 154(2):295-9. PubMed ID: 2105017
[TBL] [Abstract][Full Text] [Related]
5. Value of dynamic enhanced magnetic resonance imaging for distinguishing between ovarian fibroma and subserous uterine leiomyoma.
Thomassin-Naggara I; Daraï E; Nassar-Slaba J; Cortez A; Marsault C; Bazot M
J Comput Assist Tomogr; 2007; 31(2):236-42. PubMed ID: 17414760
[TBL] [Abstract][Full Text] [Related]
6. High-signal-intensity rim surrounding uterine leiomyomas on MR images: pathologic correlation.
Mittl RL; Yeh IT; Kressel HY
Radiology; 1991 Jul; 180(1):81-3. PubMed ID: 2052728
[TBL] [Abstract][Full Text] [Related]
7. Enlarged uterus: differentiation between adenomyosis and leiomyoma with MR imaging.
Togashi K; Ozasa H; Konishi I; Itoh H; Nishimura K; Fujisawa I; Noma S; Sagoh T; Minami S; Yamashita K
Radiology; 1989 May; 171(2):531-4. PubMed ID: 2704819
[TBL] [Abstract][Full Text] [Related]
8. Uterine Artery Embolization of Uterine Leiomyomas: Predictive MRI Features of Volumetric Response.
Kurban LAS; Metwally H; Abdullah M; Kerban A; Oulhaj A; Alkoteesh JA
AJR Am J Roentgenol; 2021 Apr; 216(4):967-974. PubMed ID: 33594913
[No Abstract] [Full Text] [Related]
9. [Role of magnetic resonance imaging (MRI) in establishing the indication for, planning, and following up uterine artery embolization (UAE) for treating symptomatic leiomyomas of the uterus].
Kröncke TJ; Hamm B
Radiologe; 2003 Aug; 43(8):624-33. PubMed ID: 14504762
[TBL] [Abstract][Full Text] [Related]
10. Uterine leiomyoma: correlation between signal intensity on magnetic resonance imaging and pathologic characteristics.
Swe TT; Onitsuka H; Kawamoto K; Ueyama T; Tsuruchi N; Masuda K
Radiat Med; 1992; 10(6):235-42. PubMed ID: 1287735
[TBL] [Abstract][Full Text] [Related]
11. Development of a Model for the Prediction of Treatment Response of Uterine Leiomyomas after Uterine Artery Embolization.
Chung YJ; Kang SY; Chun HJ; Rha SE; Cho HH; Kim JH; Kim MR
Int J Med Sci; 2018; 15(14):1771-1777. PubMed ID: 30588202
[No Abstract] [Full Text] [Related]
12. Investigating the diagnostic value of quantitative parameters based on T2-weighted and contrast-enhanced MRI with psoas muscle and outer myometrium as internal references for differentiating uterine sarcomas from leiomyomas at 3T MRI.
Malek M; Rahmani M; Seyyed Ebrahimi SM; Tabibian E; Alidoosti A; Rahimifar P; Akhavan S; Gandomkar Z
Cancer Imaging; 2019 Apr; 19(1):20. PubMed ID: 30935419
[TBL] [Abstract][Full Text] [Related]
13. MR detection of degenerating uterine leiomyomas.
Okizuka H; Sugimura K; Takemori M; Obayashi C; Kitao M; Ishida T
J Comput Assist Tomogr; 1993; 17(5):760-6. PubMed ID: 8370831
[TBL] [Abstract][Full Text] [Related]
14. Red degeneration of uterine leiomyoma: MR appearance.
Kawakami S; Togashi K; Konishi I; Kimura I; Fukuoka M; Mori T; Konishi J
J Comput Assist Tomogr; 1994; 18(6):925-8. PubMed ID: 7962801
[TBL] [Abstract][Full Text] [Related]
15. Uterine leiomyomas: correlation of MR, histopathologic findings, and symptoms.
Hricak H; Tscholakoff D; Heinrichs L; Fisher MR; Dooms GC; Reinhold C; Jaffe RB
Radiology; 1986 Feb; 158(2):385-91. PubMed ID: 3753623
[TBL] [Abstract][Full Text] [Related]
16. MR imaging in the evaluation of benign uterine masses: value of gadopentetate dimeglumine-enhanced T1-weighted images.
Hricak H; Finck S; Honda G; Göranson H
AJR Am J Roentgenol; 1992 May; 158(5):1043-50. PubMed ID: 1566664
[TBL] [Abstract][Full Text] [Related]
17. Magnetic resonance imaging of the uterus in vivo and in vitro at an ultra low magnetic field (0.02 T): assessment of its normal structure and of leiomyomas.
Varpula M; Kiilholma P; Klemi P; Komu M
Magn Reson Imaging; 1994; 12(8):1139-45. PubMed ID: 7854019
[TBL] [Abstract][Full Text] [Related]
18. Hypointensity on postcontrast MR imaging from compression of the sacral promontory in enlarged uterus with huge leiomyoma and adenomyosis.
Uotani K; Monzawa S; Adachi S; Takemori M; Kaji Y; Sugimura K
Magn Reson Med Sci; 2007; 6(2):61-6. PubMed ID: 17690535
[TBL] [Abstract][Full Text] [Related]
19. T2 hyperintense myometrial tumors: can MRI features differentiate leiomyomas from leiomyosarcomas?
Rio G; Lima M; Gil R; Horta M; Cunha TM
Abdom Radiol (NY); 2019 Oct; 44(10):3388-3397. PubMed ID: 31250178
[TBL] [Abstract][Full Text] [Related]
20. Quantitative MRI of uterine leiomyomas during triptorelin treatment: reproducibility of volume assessment and predictability of treatment response.
Broekmans FJ; Heitbrink MA; Hompes PG; Schoute E; Falke T; Schoemaker J
Magn Reson Imaging; 1996; 14(10):1127-35. PubMed ID: 9065902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
